Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bevacizumab

Known as: Anti-VEGF Humanized Monoclonal Antibody, Anti-VEGF Monoclonal Antibody, Monoclonal Antibody Anti-VEGF 
A drug used to treat several types of cancer, including certain types of colorectal, lung, breast, and kidney cancers and glioblastoma. It is also… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Tumor blood vessels are a key target for cancer therapeutic management. Tumor cells secrete high levels of pro-angiogenic factors… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2017
Review
2017
Renal cell carcinoma (RCC) denotes cancer originated from the renal epithelium and accounts for >90% of cancers in the kidney… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Recent strategies for the treatment of cancer, other than just tumor cell killing have been under intensive development, such as… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2017
Review
2017
BACKGROUND AND PURPOSE Both stereotactic radiotherapy (SRT) and immune- or targeted therapy play an increasingly important role… Expand
Is this relevant?
Review
2017
Review
2017
Background The NHS Cancer Drugs Fund (CDF) was established in 2010 to reduce delays and improve access to cancer drugs, including… Expand
Is this relevant?
Review
2017
Review
2017
Purpose Treatment options for neuroendocrine tumors (NETs) remain limited. This trial assessed the progression-free survival (PFS… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2017
Review
2017
Glioblastoma (GBM) is the most common, and aggressive, primary brain tumor in adults. With a median patient survival of less than… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Review
2017
Review
2017
Purpose The KEYNOTE-028 trial ( ClinicalTrials.gov identifier: NCT02054806) was designed to assess the safety and efficacy of… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Review
2017
Review
2017
Glioblastoma (GBM) is a severe malignant brain cancer with poor overall survival. Conventional intervention remains dismal to… Expand
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Review
2016
Review
2016
PURPOSE To investigate the structural integrity of the superficial capillary plexuses (SCPs) and deep capillary plexuses (DCPs… Expand
Is this relevant?